title: The effect of GM-CSF and G-CSF on human neutrophil function.
abstract: A direct comparison of GM-CSF and G-CSF in a panel of in vitro neutrophil-function assays was performed to investigate any differences in activity profiles. In our modified chemotactic assay, GM-CSF rapidly increased the migratory capacity of polymorphonuclear cells (PMNs) to move toward fMLP and LTB4. In contrast, G-CSF only stimulated PMN migration towards fMLP. GM-CSF, but not G-CSF, increased PMN cytotoxic killing of C. albicans blastospores. The expression of PMN surface antigens associated with Fc- and complement-mediated cell-binding (Fc gamma R1, CR-1 and CR-3), and adhesion signalling (ICAM-1), was increased after the exposure of GM-CSF, but not to G-CSF. In contrast these CSFs demonstrated relative equipotency in their ability to induce PMN anti-bacterial phagocytosis, and to restore the Staphylococcus aureus killing capacity of dexamethasone-suppressed neutrophils. The phagocytic activity of PMNs for opsonized yeast, as well as hexose-monophosphate shunt activity, was equivalent following GM-CSF or G-CSF treatment. We discuss the significance of the difference in activity profiles in this article.
authors.affiliation: Schering-Plough Research Institute, Department of Immunology, Kenilworth, NJ 07033, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Bober
authors.forename: M J
authors.initials: MJ
authors.lastname: Grace
authors.forename: C
authors.initials: C
authors.lastname: Pugliese-Sivo
authors.forename: A
authors.initials: A
authors.lastname: Rojas-Triana
authors.forename: T
authors.initials: T
authors.lastname: Waters
authors.forename: L M
authors.initials: LM
authors.lastname: Sullivan
authors.forename: S K
authors.initials: SK
authors.lastname: Narula
mesh_terms: D000954:Antigens, Surface / Q000378:metabolism; D002176:Candida albicans / Q000276:immunology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007975:Leukotriene B4 / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D010587:Phagocytosis / Q000187:drug effects; D013211:Staphylococcus aureus / Q000276:immunology
chemical_list: D000954:Antigens, Surface; D016179:Granulocyte Colony-Stimulating Factor; D007975:Leukotriene B4; D009240:N-Formylmethionine Leucyl-Phenylalanine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor